You have read all your free articles, to continue reading subscribe to read the rest of this content.
CareDx's offer to the shareholders of Swedish Allenex has been accepted by shareholders holding an aggregate of 118,207,862 shares, corresponding to approximately 98.3% of the total number of shares in Allenex. CareDx declares the offer unconditional and completes the offer. The settlement is eAlready a subscriber Login You have read…
AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K. The company announced on March 26 that it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. According to a statement the purchase was valued at approximately JPY10 billion ($1Already a subscriber Login You have read all your…
Dilaforette, focused on treatments for patients with sickle-cell disease, and Arabian Gulf University, based in Bahrain, have signed a Clinical Collaboration agreement for the Phase 2 proof of concept trial of sevuparin in patients with Sickle Cell Disease (SCD) experiencing acute Vaso-Occlusive CAlready a subscriber Login You have read all…
Janssen Biotech, one of the Janssen pharmaceutical companies of Johnson & Johnson has entered an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, an immuno-oncology agent currently in Phase 1 clinical studies. Under terms of the agreement, Janssen will attain Already a subscriber Login You have read all…
